Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity-Reference-Cited by-同舟云学术

Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity

Published:2020-10 Issue: Volume:257 Page:120250
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Lee Jong Youl,Park Taehoon,Hong Eunmi,Amatya Reeju,Park Kyung-Ah,Park Young-Hoon,Min Kyoung Ah,Jin Minki,Lee Sumi,Hwang Seungmi,Roh Gu Seob,Shin Meong Cheol

Funder

National Research Foundation of Korea

Ministry of Education, Science and Technology

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference51 articles.

1. Bioactive peptides from lizard venoms;Raufman;Regul. Pept.,1996

2. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent;Furman;Toxicon,2012

3. Injectable hydrogels for islet transplantation: a concise review;Shrestha;J. Pharm. Investig.,2020

4. C-terminal site-specific PEGylated Exendin-4 analog: a long-acting glucagon like Peptide-1 receptor agonist, on glycemic control and beta cell function in diabetic db/db mice;Tang;J. Pharmacol. Sci.,2018

5. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1;Lee;Bioconjugate Chem.,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically engineered long-acting Esculentin-2CHa(1−30) fusion protein with potential applicability for the treatment of NAFLD;Journal of Controlled Release;2024-08

2. Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists;Journal of Medicinal Chemistry;2023-12-20

3. The insulin long-acting chitosan – Polyethyleneimine nanoparticles to treat the type 2 diabetes mellitus and prevent the associated complications;International Journal of Pharmaceutics;2023-03

4. A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation;Biomaterials;2023-03

5. A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery;Journal of Pharmaceutical Investigation;2022-03